MedCity News March 11, 2025
Many experts – be they venture capitalists or private equity investprs – shared their advice to biotech entrepreneurs navigating a tough funding envornment.
The buzz and excitement at JPM might well have been from another era. On Tuesday, the second and final day of of the Investival Showcase USA in Miami, the mood was decidedly glum when it came to raising capital.
From early stage investors to private equity experts and operators, the only question was how to survive the current funding environment. Investors have an appetite for risk but generally prefer market certainty. They can pay for disruption as long as markets are not disruptive. And that has precisely what has shifted markedly in the past two months. U.S....
Today's Sponsors
Today's Sponsor